Academic Journal
Q1Molecular Neurodegeneration
About Molecular Neurodegeneration
Molecular Neurodegeneration is a scholarly journal published by an academic publisher (United Kingdom).
Key facts: ISSN 1750-1326; H-index 170; Research areas: Alzheimer's disease research and treatments; Neuroinflammation and Neurodegeneration Mechanisms; Parkinson's Disease Mechanisms and Treatments; Amyotrophic Lateral Sclerosis Research.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Alzheimer's disease research and treatments; Neuroinflammation and Neurodegeneration Mechanisms; Parkinson's Disease Mechanisms and Treatments; Amyotrophic Lateral Sclerosis Research; Dementia and Cognitive Impairment Research; Genetic Neurodegenerative Diseases.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson’s disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation
Paola Caroppo, Vittoria Aprea, Cristina Villa, Ilaria Linda Dellarole et al.
2026-10-01 · DOI: 10.1186/s13024-026-01000-9Oxidative stress-induced microglial CD22 upregulation impairs phagocytosis and exacerbates Huntington’s disease
Yan Hua Lee, Jian Jing Siew, Chia-Wei Lee, Hui-Mei Chen et al.
2026-10-01 · DOI: 10.1186/s13024-026-00996-4From mechanism to intervention: lipoproteins and Alzheimer’s disease
Tetiana Poliakova, Lizi Zhang, Cheryl L. Wellington
2026-09-26 · DOI: 10.1186/s13024-026-00993-7Dynamic [18F]PI-2620 recording facilitates prediction of β-amyloid positivity and simultaneous staging of tau and neurodegeneration
Johannes Gnörich, Julia Kusche-Palenga, Agnes Kling, Amir Dehsarvi et al.
2026-09-24 · DOI: 10.1186/s13024-026-00997-3Astrocyte reactivity identifies p-tau217-positive individuals at elevated risk of cognitive decline across the Alzheimer’s disease continuum
Bruna Bellaver, Guilherme Povala, Pamela C. L. Ferreira, Douglas T. Leffa et al.
2026-09-21 · DOI: 10.1186/s13024-026-00995-5Plasma GDF15 as a potential biomarker and driver of neuroinflammation and dementia risk
José M. Izquierdo
2026-09-21 · DOI: 10.1186/s13024-026-00999-1Human cellular models of the brain to study lipid homeostasis in Alzheimer’s disease and related dementias
Sarah E. Heuer, Fasih M. Ahsan, Tracy L. Young-Pearse
2026-09-19 · DOI: 10.1186/s13024-026-00992-8CSF proteomics and machine learning reveal distinct stages across the Alzheimer’s disease continuum
Saima Rathore, Eric B. Dammer, Anantharaman Shantaraman, Fang Wu et al.
2026-09-14 · DOI: 10.1186/s13024-026-00983-9Intranasal drug delivery for neurodegenerative diseases: therapeutic opportunities across molecules, organelles, and cells
Tu Chen Guan, William H. Frey II, Mei Liu, Yan Liu et al.
2026-09-12 · DOI: 10.1186/s13024-026-00994-6Retromer-targeted therapy for neurodegenerative diseases
Michele Persico, Sophronea Tuithung, Alejandra Lorenzo, Darynaisha Crawford et al.
2026-09-10 · DOI: 10.1186/s13024-026-00971-zThe YTHDF proteins modulate Alzheimer’s disease-associated brain gene signatures
Shinya Tasaki, Denis R. Avey, Nicola A. Kearns, Chunjiang Yu et al.
2026-09-05 · DOI: 10.1186/s13024-026-00986-6Inflammasomes: central mediators of neuroinflammatory neurodegeneration in Alzheimer’s and Parkinson’s disease
Clémence Tropis, Janna Jernigan Posey, Malú Gámez Tansey, Michael T. Heneka et al.
2026-09-05 · DOI: 10.1186/s13024-026-00991-9Lipid-driven membrane remodeling engages a lysosome-dependent adaptive repair program during retinal aging
Emily Tom, Fangyuan Gao, Carolina N. Franco, Adrian Wong et al.
2026-08-29 · DOI: 10.1186/s13024-026-00990-wGFAP upregulation by astrocytes attenuates tau neurofibrillary tangle pathology in a mouse model of tauopathy
Clara Muñoz-Castro, Molly A. Healey, Ayush Noori, Methasit Jaisa-aad et al.
2026-08-25 · DOI: 10.1186/s13024-026-00988-4Iron dysregulation: implications for pathology in multiple sclerosis
Dorsa Moezzi, Rianne Gorter, Atefeh Rayatpour, Rui Li et al.
2026-08-24 · DOI: 10.1186/s13024-026-00989-3Neurobiological correlates of longitudinal grey matter volume changes in preclinical Alzheimer’s disease
Wiesje Pelkmans, Raffaele Cacciaglia, Michalis Kassinopoulos, Oriol Grau-Rivera et al.
2026-08-21 · DOI: 10.1186/s13024-026-00987-5Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer’s disease research portfolio
Sharyn L. Rossi, Diane E. Bovenkamp
2026-08-21 · DOI: 10.1186/s13024-026-00984-8Disentangling the role of adaptive immunity in Alzheimer’s disease
Marco Zattoni, Ludwig Aigner
2026-08-13 · DOI: 10.1186/s13024-026-00985-7Astrocyte lipid metabolism in brain health and neurodegeneration: from regulatory hub to maladaptive stressor
Weihua Wang, Huajun Pan, Yashi Mi, Juvie Farol et al.
2026-08-01 · DOI: 10.1186/s13024-026-00981-xDeciphering the metabolome in Alzheimer’s disease
Xiaoli Yang, Yong Shen
2026-07-31 · DOI: 10.1186/s13024-026-00982-wReviews
Community Reviews
Version History
September 25, 2026 at 6:49 am
September 25, 2026